Clinical Study

Five-Year Retrospective Review of Acute Generalized Exanthematous Pustulosis

Table 2

Patient data (demographics, underlying disease, drug exposure, onset of symptoms, EuroSCAR AGEP validation, and therapy).

PatientAge (years)/sexDrug allergy historyComorbiditiesPossible etiology and duration between drug initiation and AGEPEuroSCAR scoreTherapy

128/FNoCervical carcinoma stage IIIb Omeprazole (15 days)8Topical steroid

284/MNoPulmonary tuberculosis, diverticular bleedingIsoniazid, rifampicin, pyrazinamide, and ethambutol (16 days)10Supportive

373/MNoCOPD, pulmonary tuberculosisAmoxicillin (3 days)8Topical steroid

438/FYesSubmucous myoma, hyperthyroidismClindamycin (1 day)9Supportive

574/FNoSubarachnoid hemorrhageMeropenem (4 days)8Oral prednisolone

648/FNoCervical carcinoma stage IIIbCelecoxib (11 days)7Topical steroid

738/FNoRuptured appendicitis, Graves’ diseaseCeftriaxone (2 days)8Topical steroid

865/MNoCongestive heart failurePiperacillin/tazobactam
Levofloxacin (4 days)
7Oral prednisolone

945/MNoAccidental fingers amputationCefazolin (2 days)8Oral prednisolone

1071/FYesRheumatoid arthritis, subacute lupus erythematosus, and lymph node tuberculosisClindamycin (2 days)9Topical steroid

1153/MNoAtypical mycobacterial infectionAmikacin, clarithromycin, levofloxacin, and imipenem (25 days)9Oral prednisolone

1233/FYesMorbid obesity post-Roux-en-Y gastrojejunostomy, carcinoma of the ovaryOmeprazole (3 days)9Topical steroid

1368/FNoRenal failure, old stroke, and sepsis with pancytopeniaMeropenem (1 hour)8Topical steroid

1438/MYesNoAmoxicillin (2 days)9Oral prednisolone

1531/MNoUpper respiratory tract infectionHerbal medicine (1 day)6Topical steroid

1673/MNoChronic kidney disease with infected arteriovenous fistulaVancomycin (21 days)7Topical steroid

1776/MNoDouble-vessel disease admitting for coronary artery bypass graftImipenem (4 days)6Topical steroid

1819/FNoDonor for liver transplantationCefoxitin (3 days)8Topical steroid

1936/MNoNoViral infection9Oral prednisolone

COPD, chronic obstructive pulmonary disease.